Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

56.1K
Overview
56.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

160
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
160
Inflammatory Response01:28

Inflammatory Response

11.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
11.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

62
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
62
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

2.3K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.3K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

76
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
76

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-chain polyunsaturated fatty acid lipid and oxylipin alterations in postoperative delirium after cardiac surgery.

Journal of lipid research·2025
Same author

12-Lipoxygenase Regulates Cold Adaptation and Glucose Metabolism by Producing the Omega-3 Lipid 12-HEPE from Brown Fat.

Cell metabolism·2025
Same author

Exercise-Stimulated Resolvin Biosynthesis in the Adipose Tissue Is Abrogated by High-Fat Diet-Induced Adrenergic Deficiency.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration.

Immunity·2025
Same author

Improving Functional Muscle Regeneration in Volumetric Muscle Loss Injuries by Shifting the Balance of Inflammatory and Pro-Resolving Lipid Mediators.

bioRxiv : the preprint server for biology·2024
Same author

Exercise-stimulated Resolvin Biosynthesis in Adipose Tissue is Abrogated by High Fat Diet-induced Adrenergic Deficiency.

bioRxiv : the preprint server for biology·2024

Related Experiment Video

Updated: Oct 10, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.4K

Proresolving receptor tames inflammation in atherosclerosis.

Hebe Agustina Mena, Matthew Spite

    The Journal of Clinical Investigation
    |December 15, 2021
    PubMed
    Summary

    GPR32, a receptor for proresolving mediators, is reduced in atherosclerosis. Overexpressing GPR32 in mice decreased lesion size and inflammation, suggesting GPR32 as a therapeutic target for atherosclerosis.

    Area of Science:

    • Cardiovascular Research
    • Immunology
    • Molecular Medicine

    Background:

    • Atherosclerosis involves chronic inflammation and immune cell infiltration in arterial plaques.
    • Nonresolving inflammation drives the progression of this cardiovascular disease.

    Purpose of the Study:

    • To investigate the role of G protein-coupled receptor 32 (GPR32) in atherosclerosis.
    • To explore GPR32 as a potential therapeutic target for resolving inflammation in atherosclerosis.

    Main Methods:

    • Quantified GPR32 expression in human atherosclerotic lesions.
    • Overexpressed human GPR32 in mouse models of atherosclerosis.
    • Assessed effects on lesion area, necrosis, cytokine production, macrophage phagocytosis, and leukocyte accumulation.

    More Related Videos

    Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
    12:50

    Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

    Published on: September 15, 2017

    6.7K
    In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
    09:43

    In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis

    Published on: August 4, 2011

    18.2K

    Related Experiment Videos

    Last Updated: Oct 10, 2025

    A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
    05:51

    A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

    Published on: May 6, 2014

    13.4K
    Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
    12:50

    Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

    Published on: September 15, 2017

    6.7K
    In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
    09:43

    In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis

    Published on: August 4, 2011

    18.2K

    Main Results:

    • GPR32 levels were decreased in human atherosclerotic lesions.
    • GPR32 overexpression in mice reduced atherosclerotic lesion area and necrosis.
    • GPR32 signaling inhibited proinflammatory cytokine production and leukocyte infiltration while enhancing macrophage phagocytosis.

    Conclusions:

    • GPR32 plays a protective role in atherosclerosis by mitigating inflammation.
    • Targeting GPR32 represents a potential therapeutic strategy for resolving chronic inflammation in atherosclerosis.